Russia is facing a shortage of Latuda (lurasidone), developed by Japan’s Sumitomo Pharma, which is a drug used to treat schizophrenia and bipolar disorder type 1. According to some Russian media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results